Vetoquinol SA (LON:0O1O)
London · Delayed Price · Currency is GBP · Price in EUR 88.80
+3.10 (3.62%)
Feb 12, 2026, 1:42 PM GMT
Vetoquinol Market Cap
Vetoquinol has a market cap or net worth of 919.66 million as of February 12, 2026. Its market cap has increased by 32.27% in one year.
Market Cap
919.66M
Enterprise Value
777.06M
Revenue
456.36M
Ranking
n/a
PE Ratio
17.89
Stock Price
88.80
Market Cap Chart
Since November 17, 2006, Vetoquinol's market cap has increased from 164.55M to 919.66M, an increase of 458.90%. That is a compound annual growth rate of 9.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 919.66M | 7.03% |
| Dec 31, 2025 | 859.23M | 17.24% |
| Dec 31, 2024 | 732.91M | -30.29% |
| Dec 29, 2023 | 1.05B | 14.39% |
| Dec 30, 2022 | 919.08M | -29.90% |
| Dec 31, 2021 | 1.31B | 47.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.40B |
| GSK plc | 86.64B |
| Haleon | 34.95B |
| Smith & Nephew | 10.82B |
| Oxford Nanopore Technologies | 1.36B |
| Oxford Biomedica | 1.00B |
| CVS Group | 958.33M |
| Spire Healthcare Group | 806.75M |